Embecta Corp. (EMBC) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Embecta reported revenue of $1.08B, down 3.8% from $1.12B the year before. Net income was $95.4M (a 8.8% net margin), or $1.62 per diluted share. Gross margin was 62.6% and operating margin was 22.4%. Operating activities generated $191.7M of cash, leaving $182.4M of free cash flow. At fiscal year end, Embecta held $1.09B in total assets against $1.74B in total liabilities, including $225.5M of cash and equivalents.
Open the full interactive Embecta financials → Quarterly statements, key ratios, valuation history and price charts.
Embecta Key Stats
| Share Price | $6.20 |
|---|---|
| Market Cap | $362.8M |
| P/E Ratio | 3.8 |
| Revenue YoY Growth | -3.8% |
| 52-Week Range | $2.89 – $14.17 |
| Shares Outstanding | 58.5 million (basic, 2026 Q3) |
Embecta Income Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $1.13B | $1.12B | $1.12B | $1.08B |
| Cost of Goods Sold | $354.6M | $370.9M | $387.9M | $403.6M |
| Gross Profit | $774.9M | $749.9M | $735.2M | $676.8M |
| Operating Income | $309.6M | $221.5M | $166.8M | $242.1M |
| Pre-Tax Income | $256.6M | $105.7M | $44.2M | $136.3M |
| Income Tax | $33.0M | $35.3M | -$34.1M | $40.9M |
| Net Income | $223.6M | $70.4M | $78.3M | $95.4M |
| Diluted EPS | $3.89 | $1.22 | $1.34 | $1.62 |
Embecta Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | |
|---|---|---|---|---|
| Revenue | $264.0M | $261.2M | $221.8M | $271.7M |
| Net Income | $26.4M | $44.1M | -$4.1M | $21.1M |
| Diluted EPS | $0.45 | $0.74 | -$0.07 | $0.36 |
Embecta Balance Sheet
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash & Equivalents | $330.9M | $326.5M | $267.5M | $225.5M |
| Current Assets | $664.7M | $749.1M | $761.0M | $631.4M |
| Total Assets | $1.09B | $1.21B | $1.29B | $1.09B |
| Current Liabilities | $301.0M | $353.5M | $374.0M | $261.5M |
| Total Long-Term Debt | $1.61B | $1.60B | $1.57B | $1.40B |
| Total Liabilities | $1.98B | $2.04B | $2.02B | $1.74B |
| Shareholders' Equity | -$891.4M | -$821.7M | -$738.3M | -$650.6M |
Embecta Cash Flow Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash From Operations | $412.2M | $67.7M | $35.7M | $191.7M |
| Cash From Investing | -$24.0M | -$26.5M | -$15.8M | -$9.3M |
| Cash From Financing | -$48.0M | -$48.7M | -$73.4M | -$226.7M |
| Free Cash Flow | $388.6M | $41.2M | $19.9M | $182.4M |
Figures from Embecta's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Embecta financials page for every line item.
Embecta Company Profile
| Ticker | EMBC |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Parsippany, New Jersey |
| Incorporated in | Delaware |
| Fiscal Year End | September 30 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001872789 |
Frequently Asked Questions
What was Embecta's revenue in fiscal 2025?
Embecta (EMBC) reported revenue of $1.08B for fiscal 2025.
What is Embecta's annual revenue history?
Embecta's annual revenue by fiscal year: 2022: $1.13B; 2023: $1.12B; 2024: $1.12B; 2025: $1.08B.
What was Embecta's net income in fiscal 2025?
Embecta reported net income of $95.4M for fiscal 2025.
What was Embecta's earnings per share (EPS) in fiscal 2025?
Embecta's diluted EPS was $1.62 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Embecta generate in fiscal 2025?
Embecta generated $182.4M of free cash flow in fiscal 2025.
What was Embecta's revenue last quarter?
In its most recent reported quarter (2026 Q3), Embecta reported revenue of $271.7M.
How much debt does Embecta have?
Embecta reported $1.40B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Embecta are outstanding?
Embecta reported a weighted average of 58.5 million basic shares outstanding in 2026 Q3.
What is Embecta's market cap?
Based on its latest closing price, Embecta (EMBC) has a market capitalization of about $362.8M.
When does Embecta's fiscal year end?
Embecta's fiscal year end, as registered with the SEC, is September 30.
Where is Embecta headquartered?
Embecta lists its business address in Parsippany, New Jersey in its SEC filings.